Bliss GVS Pharma Ltd

Bliss GVS Pharma Ltd

Next 500 2022
+ 4 More
+ 4 More
OVERVIEW
FINANCIALS

Featured In Fortune India Ranking

Next 500 India
#456(2022)#390(2021)#339(2020)#329(2019)#366(2018)
#456(2022)#390(2021)#339(2020)#329(2019)#366(2018)
Ranking Trend Fortune Next 500 India

Financial Data 2024

Revenue
807
(INR Cr)
Net Operating Income
770
(INR Cr)
Assets
1,105
(INR Cr)
Profit
75
(INR Cr)
Net Worth
967
(INR Cr)

Financial Data

RevenueNet Operating IncomeProfitAssetsNet Worth
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Revenue
(INR Cr)
807
8.7%
742
-8.1%
808
32.6%
609
-15.9%
724
-23.2%
943
12.0%
842
2.6%
821
42.6%
575
35.8%
424
13.6%
373
-10.5%
417
47.2%
283
28.0%
221
28.8%
172
23.1%
140
-
Net Operating Income
(INR Cr)
770
2.48%
752
0.55%
747
29.49%
577
-16.26%
689
-23.29%
899
10.30%
815
2.03%
798
45.99%
547
34.33%
407
18.13%
345
-13.11%
397
48.73%
267
21.86%
219
0.00%
169
27.03%
133
29.85%
Profit
(INR Cr)
75
6.5%
71
371.1%
15
-78.0%
68
-29.6%
97
-21.4%
124
110.4%
59
-28.4%
82
-0.5%
82
37.7%
60
46.2%
41
-29.0%
58
9.9%
53
29.3%
41
-2.6%
42
11.4%
37
-
Assets
(INR Cr)
1105
8.2%
1022
6.8%
957
0.5%
952
8.3%
879
15.1%
764
14.4%
668
-14.5%
780
34.8%
579
12.9%
513
9.0%
471
12.1%
420
63.9%
256
46.1%
175
24.6%
141
40.9%
100
-
Net Worth
(INR Cr)
967
9.4%
884
8.0%
819
1.3%
808
9.9%
736
13.9%
646
20.5%
536
10.2%
487
17.9%
413
22.4%
337
17.5%
287
11.2%
258
22.5%
211
26.4%
167
0.0%
133
36.6%
98
57.6%
Employee Cost
(INR Cr)
96
10.9%
86
13.2%
76
11.8%
68
26.8%
54
26.9%
42
-38.9%
69
12.8%
61
81.8%
34
14.6%
29
25.5%
23
55.6%
15
146.0%
6
42.2%
4
65.8%
3
22.6%
2
-
Interest Cost
(INR Cr)
71056842320191618104222
Cash & Bank Balance
(INR Cr)
21610317814510310789151785780505818157
Total Debt
(INR Cr)
10010210912212610211822513216017314845882

Key Financial Ratios

Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
PARAMETERS2024202320222021202020192018201720162015201420132012201120102009
Profit As % Of Revenues 9.4%9.5%1.9%11.2%13.4%13.1%7.0%10.0%14.3%14.1%11.0%13.8%18.6%18.4%24.3%26.8%
Profit As % Of Assets 6.8%6.9%1.6%7.2%11.1%16.2%8.8%10.5%14.2%11.7%8.7%13.7%20.5%23.2%29.6%37.5%
Profit As % Of Networth 7.8%8.0%1.8%8.5%13.2%19.2%11.0%16.9%20.0%17.8%14.3%22.4%24.9%24.4%31.3%38.4%
Interest Cost to EBITDA % 5.7%8.8%10.6%5.2%6.9%2.8%14.0%9.7%12.0%15.9%25.3%8.7%5.7%3.7%4.0%5.8%
Debt to Equity Ratio 0.100.120.130.150.170.160.220.460.320.470.600.570.210.050.060.02
RONW 11.0%9.0%5.4%9.6%13.8%21.4%20.9%25.1%26.7%19.7%14.7%24.7%27.9%24.4%36.2%47.0%
ROCE 14.8%12.1%14.2%12.2%16.9%26.5%29.0%31.0%32.0%23.5%20.1%35.3%38.7%31.4%39.7%51.4%